Companies / Kymera Therapeutics, Inc. / Activity
Activity — Kymera Therapeutics, Inc.
109 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Gollob Jared Executive | Sell | Common Stock | $214.2K | -3K -2.07% | 119,018 0.14% of shares | medium |
| Mar 4, 2026 | Jacobs Bruce N. Executive | Sell | Common Stock | $214.2K | -3K -1.06% | 234,472 0.28% of shares | medium |
| Mar 31, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $225.3K | +8K +12.42% | 68,802 0.08% of shares | low |
| Mar 2, 2026 | Gollob Jared Executive | Sell | Common Stock | $273.3K | -3K -2.44% | 122,029 0.15% of shares | medium |
| May 26, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $292.3K | -4K -6.09% | 57,472 0.07% of shares | medium |
| May 27, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $299.8K | -4K -7.62% | 44,618 0.05% of shares | medium |
| May 26, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $301.7K | -4K -6.65% | 53,348 0.06% of shares | medium |
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $302.2K | -3K -0.49% | 667,704 0.80% of shares | medium |
| Jan 20, 2026 | Esposito Pamela Director | Sell | Common Stock | $333.1K | -5K -96.08% | 200 <0.01% of shares | medium |
| May 26, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $360.1K | -5K -8.44% | 48,848 0.06% of shares | medium |
| Mar 2, 2026 | Jacobs Bruce N. Executive | Sell | Common Stock | $368.8K | -4K -1.70% | 237,483 0.29% of shares | medium |
| Apr 1, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $433.9K | +15K +23.92% | 75,842 0.09% of shares | low |
| Apr 14, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $472.6K | -5K -7.90% | 61,202 0.07% of shares | medium |
| Mar 23, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $487.6K | -6K -8.91% | 62,402 0.08% of shares | medium |
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $491.2K | -5K -0.80% | 670,997 0.81% of shares | medium |
| Mar 23, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $644.0K | -8K -10.71% | 68,507 0.08% of shares | medium |
| Mar 31, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $648.9K | -8K -11.05% | 61,202 0.07% of shares | medium |
| Mar 25, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $732.9K | +25K +40.40% | 85,929 0.10% of shares | low |
| Mar 11, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $870.0K | +20K +27.10% | 93,810 0.11% of shares | low |
| Mar 2, 2026 | Booth Bruce Director | Sell | Common Stock | $906.0K | -10K -1.47% | 675,341 0.81% of shares | medium |
| Mar 11, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $930.2K | -11K -14.04% | 68,052 0.08% of shares | medium |
| Mar 11, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $1.07M | -13K -14.00% | 79,163 0.10% of shares | medium |
| Apr 1, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $1.16M | -14K -17.85% | 62,302 0.07% of shares | medium |
| Mar 23, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $1.75M | -23K -14.93% | 129,696 0.16% of shares | medium |
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $1.77M | -20K -2.84% | 676,431 0.81% of shares | medium |
| Mar 25, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $1.98M | -25K -28.78% | 61,202 0.07% of shares | medium |
| Mar 23, 2026 | Chadwick Jeremy G Executive | Exercise | Common Stock | $2.50M | +84K +124.02% | 152,452 0.18% of shares | low |
| Mar 23, 2026 | Chadwick Jeremy G Executive | Sell | Common Stock | $4.09M | -53K -40.85% | 76,721 0.09% of shares | medium |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $5.52M | -52K -39.69% | 78,787 0.09% of shares | medium |
| Mar 2, 2026 | Booth Bruce Director | Sell | Common Stock | $6.47M | -72K -1.81% | 3,902,667 4.69% of shares | medium |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $12.07M | -113K -32.06% | 240,123 0.29% of shares | high |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $66.84M | -628K -28.27% | 1,592,261 1.91% of shares | high |
| Jun 26, 2026 | Bvf Partners L P/IL Director | Sell | Common Stock, $0.0001 par value | $89.24M | -838K -29.94% | 1,960,881 2.36% of shares | high |
| Apr 22, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -200 -0.34% | 58,263 0.07% of shares | low |
| Apr 22, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -100 -0.22% | 45,434 0.05% of shares | low |
| Apr 15, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -1K -2.18% | 58,463 0.07% of shares | low |
| Apr 14, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -785 -1.30% | 59,763 0.07% of shares | low |
| Apr 14, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -4K -8.93% | 45,534 0.05% of shares | low |
| Apr 1, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -15K -17.58% | 68,633 0.08% of shares | low |
| Mar 31, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -8K -8.36% | 83,273 0.10% of shares | low |
| Jun 24, 2026 | Maraganore John Director | Grant | Stock Option (Right to Buy) | — | +6K | 6,068 <0.01% of shares | low |
| Jun 24, 2026 | Baker Bros. Advisors LP Director | Grant | Non-Qualified Stock Option (right to buy) | — | +6K | 6,068 <0.01% of shares | low |
| Jun 24, 2026 | Baker Bros. Advisors LP Director | Grant | Non-Qualified Stock Option (right to buy) | — | +6K | 6,068 <0.01% of shares | low |
| Jun 24, 2026 | Bvf Partners L P/IL Director | Grant | Stock Option (Right to Buy) | — | +6K | 6,068 <0.01% of shares | low |
| Mar 2, 2026 | Gollob Jared Executive | Grant | Stock Option (Right to Buy) | — | +35K | 35,300 0.04% of shares | low |
| Mar 2, 2026 | Mainolfi Nello CEO | Grant | Stock Option (Right to Buy) | — | +215K | 215,000 0.26% of shares | low |
| Feb 25, 2026 | Mainolfi Nello CEO | Exercise | Stock Option (Right to Buy) | — | -30K -10.89% | 245,559 0.30% of shares | low |
| Jan 5, 2026 | Mainolfi Nello CEO | Exercise | Stock Option (Right to Buy) | — | -3K -0.69% | 446,882 0.54% of shares | low |
| Mar 2, 2026 | Jacobs Bruce N. Executive | Grant | Stock Option (Right to Buy) | — | +35K | 35,300 0.04% of shares | low |
| Mar 25, 2026 | Chadwick Jeremy G Executive | Exercise | Stock Option (Right to Buy) | — | -25K -21.39% | 90,873 0.11% of shares | low |